Answers are grounded in this paper and cite their sources.
Introduction: the lesbian, gay, bisexual, transgender, queer/ questioning, intersex, and asexual/aromantic/agender (lGBtQiA+) community faces a significantly higher risk of eating disorders (eDs).this review's primary objective is to explore eD treatments for this population.Methods: we searched PubMed/MeDliNe and PsyciNFO using the keywords "eD, " "lGBtQiA+, " and "therapy, " following the Preferred Reporting items for Systematic Review and Meta-Analysis extension for Scoping Reviews 2018 checklist.Results: Out of 363 publications, we identified 14 articles and inductively categorized them into two key macro-themes.the primary macro-theme "conventional treatments applied to the lGBtQiA+ population" encompassed both treatment outcomes, which demonstrated overall effectiveness, and self-reported treatment evaluations, which consistently indicated negative experiences.the secondary macro-theme, "specific treatments for the lGBtQiA+ population, " centered on population-targeted treatments, which, while currently limited, displayed promising results, including improvements in eD psychopathology through gender transition.Conclusions: the existing literature indicates that conventional treatments are effective in symptom relief but occur within a context marked by perceived discrimination based on gender identity and sexual orientation.concurrently, population-specific interventions hold promise in reducing eD symptoms, with gender transition emerging as a valuable treatment.Further research is needed to develop tailored treatments and address the challenges faced by the lGBtQiA+ community.
No takes yet. Share an insight, caveat, or question.
Valenta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: